PAVmed (PAVM) Cash from Investing Activities (2016 - 2025)
PAVmed's (PAVM) quarterly Cash from Investing Activities came in at -$14000.0 in Q4 2025, down 250.0% year-on-year from $9333.3 in Q4 2024, and down 366.67% quarter-over-quarter from -$3000.0 in Q3 2025.
PAVmed (PAVM) Cash from Investing Activities (2016 - 2025) Analysis & Trends
PAVmed's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$14000.0 for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 250.0% year-over-year to -$14000.0 in Q4 2025; TTM through Dec 2025 was -$31000.0, a 86.64% increase from a year earlier, with the FY2025 full-year figure at -$31000.0, up 99.81% from the prior year.
- Cash from Investing Activities eased to -$14000.0 in Q4 2025 per PAVM's latest filing, from -$3000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $974000.0 in Q1 2023 and bottomed at -$3.4 million in Q4 2021.
- The 5-year median for Cash from Investing Activities is -$36000.0 (2021), against an average of -$409368.4.
- Across the five-year window, Cash from Investing Activities tumbled 42112.5% in 2021 and soared 269.69% in 2023, its largest moves.
- Year by year, Cash from Investing Activities stood at -$3.4 million in 2021, then jumped by 91.18% to -$298000.0 in 2022, then surged by 38.59% to -$183000.0 in 2023, then surged by 97.81% to -$4000.0 in 2024, then slumped by 250.0% to -$14000.0 in 2025.
- Per Business Quant, the three latest PAVM Cash from Investing Activities figures stand at -$14000.0 (Q4 2025), -$3000.0 (Q3 2025), and -$8000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -475.32 Mn |
| 10 | PAVmed | 10.82 Mn | 9.28 Mn | -4,000.00 | -14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Dec 31, 2023 | -183,000.00 |
| Dec 31, 2023 | -183,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -15,000.00 |